Ketuo Bio will exclusively sponsor a number of clinical research projects at the 2021 China Intestinal Conference officially launched

From May 28 to May 30, 2021, the 2021 China Gut Congress was successfully held in Nanjing International Convention and Exhibition Center. As the largest intestinal-themed academic feast in China and even the world, this intestinal conference attracted doctors, experts and scholars engaged in intestinal science from all over the country to come together to talk about the latest research results and industrial applications of intestinal science. During the 2021 China Intestinal Conference, Ketuo Bio is not only the exclusive main sponsor of the conference, but also hosted the "Probiotics and Prebiotics" conference. Professor Zhang Heping, chief scientist of Ketuo Bio, brought the title "How to select and evaluate the function of probiotics" "The speech introduced the related effects of probiotics and intestinal flora, and a series of clinical trials conducted in recent years on the star strains and formulations of Ketuo Biotech. At the China Intestinal Industry Conference held at the same time, Liu Xiaojun, President of Ketuo Biotech, gave a speech titled "The Science Behind Probiotics", introducing Ketuo Biotech's advantages in the industrialization of probiotics, including strain resources. The establishment of the library, the strain screening process behind it, related basic research, industrial processing technology research and scientific evidence-based probiotic efficacy, etc. "Good probiotics must be safe and effective. This is also the advantage of Ketuo Bio's probiotics. " Bao Weichen, general manager of Ketuo Bio-strains factory, also participated in the China Intestinal Industry Conference and delivered a speech entitled "The Importance of Probiotics Key Processing Technology in Industrial Manufacturing", which systematically displayed Ketuo's Bio-strains The factory’s unique processing technology advantages in the processing of probiotics, including metabolomics culture and control, vacuum drying and cryoprotection control, etc. , achieve multi-dimensional precise control to ensure the high survival rate of strains, so as to better produce safe and effective probiotics Bacteria products. The 2021 China Intestine Conference coincides with the 529th World Intestine Day. Ketuo Biotech has been committed to the exploration and related research of intestinal health. As the exclusive main sponsor of this conference, it will be held in China Intestine on the morning of May 29th. The "Ketuo Biological Research and Development Achievement Conference" was held on the main stage of the conference industry conference. Scientific research is the soul of enterprise innovation. Adhering to scientific evidence-based research can better explore the probiotic effects of strains. It is understood that this press conference is the first concentrated display of the latest research and development results and related cooperation of Ketuo since 2021! Prof. Sun Tiansong, Chairman of Ketuo Bio, Professor Heping Zhang, Chief Scientist of Ketuo Bio, and Liu Xiaojun, President of Ketuo Bio, attended the conference. At the same time, Ketuo Bio also invited the Secretary of the Party Committee of China Resources Jiangzhong, General Manager Lu Xiaoqing and China Resources Jiang Dr. Wenjun Liu, General Manager of the Central Research and Development Department, Professor Ye Chen, Deputy Dean of Shenzhen Hospital of Southern Medical University, Deputy Director of the Department of Nephrology, Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Professor Yao Ying, Director of the Department of Clinical Nutrition, and Department of Clinical Nutrition, Shenzhen Hospital of Southern Medical University Director Zhu Cuifeng and other guests participated in this conference. The biggest highlight of this conference is the probiotic "Go to heaven" of Ketuo Bio. The experiment conducted by China Resources Jiangzhong in cooperation with China Academy of Space Technology and Aerospace Shenzhou Biotechnology Group was successfully carried by a new generation of manned spacecraft test ship. After receiving the probiotic strains of Ketuo Biotech, I returned to Earth after completing the space journey. After a series of scientific studies, many research results have been obtained. These research results were disclosed for the first time at this press conference! 　　First, Dr. Wenjun Liu, general manager of the R&D department of China Resources Jiangzhong, gave a systematic introduction to the background knowledge of aerospace probiotic strains; then Professor Zhang Heping, chief scientist of Cotuo Biotechnology, shared the latest research results of aerospace probiotic strains for the participants. 　　Professor Zhang Heping said: 　　“The aerospace strain Lactobacillus rhamnosus R7970 has strong genetic stability through genome analysis, and has a larger number of viable fermenting bacteria during fermentation; and the capsular polysaccharide of R7970 has higher resistance to the environment and improves It has improved its survival rate in the intestines and has immune activity, which also laid the foundation for subsequent research. " 　　Another highlight of this conference is the launch ceremony of 3 clinical research projects of probiotics! To this end, Ketuo’s special guests, Vice President Chen Ye, Director Yao Ying, and Director Zhu Cuifeng, respectively brought the audience the title "The Role of Probiotics in the Eradication Treatment of Helicobacter Pylori" and "Lactobacillus rhamnosus R7970" "Clinical research on regulating the gut-renal axis to intervene in nephropathy" and "Clinical study on regulating the gut-brain axis to relieve autism by Bifidobacterium lactis Probio-M8". 　　Deputy Dean Chen Ye said: 　　“Probiotics can clearly reduce the gastrointestinal side effects caused by Helicobacter pylori eradication treatment and increase the eradication rate. ” 　　Director Yao Ying said: 　　“The occurrence of chronic kidney disease is accompanied by inflammation and immune reactions, etc. Over the years, studies have found that the structure of the intestinal flora of patients with chronic kidney disease is chaotic, and probiotics can improve the structure of the intestinal flora, increase the content of beneficial bacteria, and reduce the level of inflammatory factors, thereby delaying the development of chronic kidney disease. It protects the kidneys. ” 　　Director Zhu Cuifeng said: “ Dysbiosis of the 　　intestinal flora has an impact on brain mood and mental health, which may also affect the occurrence of autism. Probiotics have plasticity in children’s intestinal flora. Stronger than adults, studies have found that probiotics can effectively improve the intestinal flora of children with autism, and effectively intervene and improve symptoms related to autism. " 　　The release of this series of research results feasted the audience! Finally, Liu Xiaojun, President of Ketuo Bio, reviewed Ketuo's research and development achievements and looked forward to the future! From the establishment of the strain resource bank, to strain screening and basic research, to the processing technology and the medical evidence behind it, a summary and prospect were made. Ketuo Biologics takes scientific research as the soul of corporate innovation, adheres to scientific evidence-based exploration of the probiotic effects of strains, and provides a complete set of product solutions based on customer needs. 　　Since its establishment, Ketuo Biotech has been adhering to a scientific and rigorous attitude, attaching great importance to scientific research and development and taking science and technology as the primary productive force. At present, more than 20,000 strains of lactic acid bacteria have been collected, separated, identified and preserved through international cooperation, and the largest strain resource bank in Asia has been established. As the saying goes, good probiotic strains are inseparable from scientific experiments. For many years, Ketuo Biosciences has carried out more than 50 clinical trials on star strains and their formulations with more than ten domestic tertiary hospitals. In the future, Ketuo Bio will still use its own advantages, adhere to scientific research, scientific evidence-based, pay attention to the research of probiotics-related probiotic effects and new breakthroughs in related industrial application technologies, and make products with heart to give back to consumers!      Disclaimer: This article only represents the author's personal views and has nothing to do with China Probiotics. com. The originality and the text and content stated in the article have not been verified by this site. This site does not make any guarantee or commitment to the authenticity, completeness, and timeliness of this article, all or part of the content, and the text. Please readers for reference only, and please Verify the relevant content yourself.      Copyright Notice    1. Some of the reprinted articles on this site are not original, and the copyright and liability belong to the original author. 2. All reprinted articles, links and pictures on this website are for the purpose of conveying more information, and clearly indicate the source and author. Media or individuals who do not want to be reprinted can contact us for infringement information that can provide sufficient evidence , Bio149 will be deleted within 12 hours after confirmation. 3. Users are welcome to post original articles to 86371366@qq. com, and publish them to the homepage after review. The copyright and liability belong to the sender.

　　From May 28 to May 30, 2021, the 2021 China Gut Congress was successfully held in Nanjing International Convention and Exhibition Center.
As the largest intestinal-themed academic feast in China and even the world, this intestinal conference attracted doctors, experts and scholars engaged in intestinal science from all over the country to come together to talk about the latest research results and industrial applications of intestinal science.
　　During the 2021 China Intestinal Conference, Ketuo Bio is not only the exclusive main sponsor of the conference, but also hosted the "Probiotics and Prebiotics" conference.
Professor Zhang Heping, chief scientist of Ketuo Bio, brought the title "How to select and evaluate the function of probiotics" "The speech introduced the related effects of probiotics and intestinal flora, and a series of clinical trials conducted in recent years on the star strains and formulations of Ketuo Biotech.

　　At the China Intestinal Industry Conference held at the same time, Liu Xiaojun, President of Ketuo Biotech, gave a speech titled "The Science Behind Probiotics", introducing Ketuo Biotech's advantages in the industrialization of probiotics, including strain resources.
The establishment of the library, the strain screening process behind it, related basic research, industrial processing technology research and scientific evidence-based probiotic efficacy, etc.
"Good probiotics must be safe and effective.
This is also the advantage of Ketuo Bio's probiotics.
"
　　Bao Weichen, general manager of Ketuo Bio-strains factory, also participated in the China Intestinal Industry Conference and delivered a speech entitled "The Importance of Probiotics Key Processing Technology in Industrial Manufacturing", which systematically displayed Ketuo's Bio-strains The factory’s unique processing technology advantages in the processing of probiotics, including metabolomics culture and control, vacuum drying and cryoprotection control, etc.
, achieve multi-dimensional precise control to ensure the high survival rate of strains, so as to better produce safe and effective probiotics Bacteria products.

　　The 2021 China Intestine Conference coincides with the 529th World Intestine Day.
Ketuo Biotech has been committed to the exploration and related research of intestinal health.
As the exclusive main sponsor of this conference, it will be held in China Intestine on the morning of May 29th.
The "Ketuo Biological Research and Development Achievement Conference" was held on the main stage of the conference industry conference.
　　Scientific research is the soul of enterprise innovation.
Adhering to scientific evidence-based research can better explore the probiotic effects of strains.
It is understood that this press conference is the first concentrated display of the latest research and development results and related cooperation of Ketuo since 2021! Prof.
Sun Tiansong, Chairman of Ketuo Bio, Professor Heping Zhang, Chief Scientist of Ketuo Bio, and Liu Xiaojun, President of Ketuo Bio, attended the conference.
At the same time, Ketuo Bio also invited the Secretary of the Party Committee of China Resources Jiangzhong, General Manager Lu Xiaoqing and China Resources Jiang Dr.
Wenjun Liu, General Manager of the Central Research and Development Department, Professor Ye Chen, Deputy Dean of Shenzhen Hospital of Southern Medical University, Deputy Director of the Department of Nephrology, Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Professor Yao Ying, Director of the Department of Clinical Nutrition, and Department of Clinical Nutrition, Shenzhen Hospital of Southern Medical University Director Zhu Cuifeng and other guests participated in this conference.
　　The biggest highlight of this conference is the probiotic "Go to heaven" of Ketuo Bio.
The experiment conducted by China Resources Jiangzhong in cooperation with China Academy of Space Technology and Aerospace Shenzhou Biotechnology Group was successfully carried by a new generation of manned spacecraft test ship.
After receiving the probiotic strains of Ketuo Biotech, I returned to Earth after completing the space journey.
After a series of scientific studies, many research results have been obtained.
These research results were disclosed for the first time at this press conference! 　　First, Dr.
Wenjun Liu, general manager of the R&D department of China Resources Jiangzhong, gave a systematic introduction to the background knowledge of aerospace probiotic strains; then Professor Zhang Heping, chief scientist of Cotuo Biotechnology, shared the latest research results of aerospace probiotic strains for the participants.
　　Professor Zhang Heping said: 　　“The aerospace strain Lactobacillus rhamnosus R7970 has strong genetic stability through genome analysis, and has a larger number of viable fermenting bacteria during fermentation; and the capsular polysaccharide of R7970 has higher resistance to the environment and improves It has improved its survival rate in the intestines and has immune activity, which also laid the foundation for subsequent research.
" 　　Another highlight of this conference is the launch ceremony of 3 clinical research projects of probiotics! To this end, Ketuo’s special guests, Vice President Chen Ye, Director Yao Ying, and Director Zhu Cuifeng, respectively brought the audience the title "The Role of Probiotics in the Eradication Treatment of Helicobacter Pylori" and "Lactobacillus rhamnosus R7970" "Clinical research on regulating the gut-renal axis to intervene in nephropathy" and "Clinical study on regulating the gut-brain axis to relieve autism by Bifidobacterium lactis Probio-M8".

　　Deputy Dean Chen Ye said: 　　“Probiotics can clearly reduce the gastrointestinal side effects caused by Helicobacter pylori eradication treatment and increase the eradication rate.
” 　　Director Yao Ying said: 　　“The occurrence of chronic kidney disease is accompanied by inflammation and immune reactions, etc.
Over the years, studies have found that the structure of the intestinal flora of patients with chronic kidney disease is chaotic, and probiotics can improve the structure of the intestinal flora, increase the content of beneficial bacteria, and reduce the level of inflammatory factors, thereby delaying the development of chronic kidney disease.
It protects the kidneys.
” 　　Director Zhu Cuifeng said: “ Dysbiosis of the 　　intestinal flora has an impact on brain mood and mental health, which may also affect the occurrence of autism.
Probiotics have plasticity in children’s intestinal flora.
Stronger than adults, studies have found that probiotics can effectively improve the intestinal flora of children with autism, and effectively intervene and improve symptoms related to autism.
" 　　The release of this series of research results feasted the audience! Finally, Liu Xiaojun, President of Ketuo Bio, reviewed Ketuo's research and development achievements and looked forward to the future! From the establishment of the strain resource bank, to strain screening and basic research, to the processing technology and the medical evidence behind it, a summary and prospect were made.
Ketuo Biologics takes scientific research as the soul of corporate innovation, adheres to scientific evidence-based exploration of the probiotic effects of strains, and provides a complete set of product solutions based on customer needs.

　　Since its establishment, Ketuo Biotech has been adhering to a scientific and rigorous attitude, attaching great importance to scientific research and development and taking science and technology as the primary productive force.
At present, more than 20,000 strains of lactic acid bacteria have been collected, separated, identified and preserved through international cooperation, and the largest strain resource bank in Asia has been established.
As the saying goes, good probiotic strains are inseparable from scientific experiments.
For many years, Ketuo Biosciences has carried out more than 50 clinical trials on star strains and their formulations with more than ten domestic tertiary hospitals.
In the future, Ketuo Bio will still use its own advantages, adhere to scientific research, scientific evidence-based, pay attention to the research of probiotics-related probiotic effects and new breakthroughs in related industrial application technologies, and make products with heart to give back to consumers!

---

　　From May 28 to May 30, 2021, the 2021 China Gut Congress was successfully held in Nanjing International Convention and Exhibition Center.
As the largest intestinal-themed academic feast in China and even the world, this intestinal conference attracted doctors, experts and scholars engaged in intestinal science from all over the country to come together to talk about the latest research results and industrial applications of intestinal science.
　　During the 2021 China Intestinal Conference, Ketuo Bio is not only the exclusive main sponsor of the conference, but also hosted the "Probiotics and Prebiotics" conference.
Professor Zhang Heping, chief scientist of Ketuo Bio, brought the title "How to select and evaluate the function of probiotics" "The speech introduced the related effects of probiotics and intestinal flora, and a series of clinical trials conducted in recent years on the star strains and formulations of Ketuo Biotech.

　　At the China Intestinal Industry Conference held at the same time, Liu Xiaojun, President of Ketuo Biotech, gave a speech titled "The Science Behind Probiotics", introducing Ketuo Biotech's advantages in the industrialization of probiotics, including strain resources.
The establishment of the library, the strain screening process behind it, related basic research, industrial processing technology research and scientific evidence-based probiotic efficacy, etc.
"Good probiotics must be safe and effective.
This is also the advantage of Ketuo Bio's probiotics.
"
　　Bao Weichen, general manager of Ketuo Bio-strains factory, also participated in the China Intestinal Industry Conference and delivered a speech entitled "The Importance of Probiotics Key Processing Technology in Industrial Manufacturing", which systematically displayed Ketuo's Bio-strains The factory’s unique processing technology advantages in the processing of probiotics, including metabolomics culture and control, vacuum drying and cryoprotection control, etc.
, achieve multi-dimensional precise control to ensure the high survival rate of strains, so as to better produce safe and effective probiotics Bacteria products.

　　The 2021 China Intestine Conference coincides with the 529th World Intestine Day.
Ketuo Biotech has been committed to the exploration and related research of intestinal health.
As the exclusive main sponsor of this conference, it will be held in China Intestine on the morning of May 29th.
The "Ketuo Biological Research and Development Achievement Conference" was held on the main stage of the conference industry conference.
　　Scientific research is the soul of enterprise innovation.
Adhering to scientific evidence-based research can better explore the probiotic effects of strains.
It is understood that this press conference is the first concentrated display of the latest research and development results and related cooperation of Ketuo since 2021! Prof.
Sun Tiansong, Chairman of Ketuo Bio, Professor Heping Zhang, Chief Scientist of Ketuo Bio, and Liu Xiaojun, President of Ketuo Bio, attended the conference.
At the same time, Ketuo Bio also invited the Secretary of the Party Committee of China Resources Jiangzhong, General Manager Lu Xiaoqing and China Resources Jiang Dr.
Wenjun Liu, General Manager of the Central Research and Development Department, Professor Ye Chen, Deputy Dean of Shenzhen Hospital of Southern Medical University, Deputy Director of the Department of Nephrology, Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Professor Yao Ying, Director of the Department of Clinical Nutrition, and Department of Clinical Nutrition, Shenzhen Hospital of Southern Medical University Director Zhu Cuifeng and other guests participated in this conference.
　　The biggest highlight of this conference is the probiotic "Go to heaven" of Ketuo Bio.
The experiment conducted by China Resources Jiangzhong in cooperation with China Academy of Space Technology and Aerospace Shenzhou Biotechnology Group was successfully carried by a new generation of manned spacecraft test ship.
After receiving the probiotic strains of Ketuo Biotech, I returned to Earth after completing the space journey.
After a series of scientific studies, many research results have been obtained.
These research results were disclosed for the first time at this press conference! 　　First, Dr.
Wenjun Liu, general manager of the R&D department of China Resources Jiangzhong, gave a systematic introduction to the background knowledge of aerospace probiotic strains; then Professor Zhang Heping, chief scientist of Cotuo Biotechnology, shared the latest research results of aerospace probiotic strains for the participants.
　　Professor Zhang Heping said: 　　“The aerospace strain Lactobacillus rhamnosus R7970 has strong genetic stability through genome analysis, and has a larger number of viable fermenting bacteria during fermentation; and the capsular polysaccharide of R7970 has higher resistance to the environment and improves It has improved its survival rate in the intestines and has immune activity, which also laid the foundation for subsequent research.
" 　　Another highlight of this conference is the launch ceremony of 3 clinical research projects of probiotics! To this end, Ketuo’s special guests, Vice President Chen Ye, Director Yao Ying, and Director Zhu Cuifeng, respectively brought the audience the title "The Role of Probiotics in the Eradication Treatment of Helicobacter Pylori" and "Lactobacillus rhamnosus R7970" "Clinical research on regulating the gut-renal axis to intervene in nephropathy" and "Clinical study on regulating the gut-brain axis to relieve autism by Bifidobacterium lactis Probio-M8".

　　Deputy Dean Chen Ye said: 　　“Probiotics can clearly reduce the gastrointestinal side effects caused by Helicobacter pylori eradication treatment and increase the eradication rate.
” 　　Director Yao Ying said: 　　“The occurrence of chronic kidney disease is accompanied by inflammation and immune reactions, etc.
Over the years, studies have found that the structure of the intestinal flora of patients with chronic kidney disease is chaotic, and probiotics can improve the structure of the intestinal flora, increase the content of beneficial bacteria, and reduce the level of inflammatory factors, thereby delaying the development of chronic kidney disease.
It protects the kidneys.
” 　　Director Zhu Cuifeng said: “ Dysbiosis of the 　　intestinal flora has an impact on brain mood and mental health, which may also affect the occurrence of autism.
Probiotics have plasticity in children’s intestinal flora.
Stronger than adults, studies have found that probiotics can effectively improve the intestinal flora of children with autism, and effectively intervene and improve symptoms related to autism.
" 　　The release of this series of research results feasted the audience! Finally, Liu Xiaojun, President of Ketuo Bio, reviewed Ketuo's research and development achievements and looked forward to the future! From the establishment of the strain resource bank, to strain screening and basic research, to the processing technology and the medical evidence behind it, a summary and prospect were made.
Ketuo Biologics takes scientific research as the soul of corporate innovation, adheres to scientific evidence-based exploration of the probiotic effects of strains, and provides a complete set of product solutions based on customer needs.

　　Since its establishment, Ketuo Biotech has been adhering to a scientific and rigorous attitude, attaching great importance to scientific research and development and taking science and technology as the primary productive force.
At present, more than 20,000 strains of lactic acid bacteria have been collected, separated, identified and preserved through international cooperation, and the largest strain resource bank in Asia has been established.
As the saying goes, good probiotic strains are inseparable from scientific experiments.
For many years, Ketuo Biosciences has carried out more than 50 clinical trials on star strains and their formulations with more than ten domestic tertiary hospitals.
In the future, Ketuo Bio will still use its own advantages, adhere to scientific research, scientific evidence-based, pay attention to the research of probiotics-related probiotic effects and new breakthroughs in related industrial application technologies, and make products with heart to give back to consumers!

---

---